Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2000-10-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Healthy Volunteers and those with mild type 2 diabetes may be eligible to participate
* This study is searching for genes that may affect the body's processing/digestion of glucose/sugar
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
NCT03685773
Incretin Regulation of Insulin Secretion in Monogenic Diabetes
NCT01795144
Insulin Resistance and Insulin Secretion
NCT00073294
Central Mechanisms That Regulate Glucose Metabolism in Humans
NCT01028846
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Entry
This group is just entering the study and will need to be genotyped.
No interventions assigned to this group
Affected
This group has been genotyped and has the gene undergoing study at that time.
No interventions assigned to this group
Control
This group has been genotyped and does not have the gene currently under study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-diabetic
* diabetes controlled with diet or with pills
* no family history of diabetes
* family history of type 2 diabetes
* personal history of gestational diabetes
Exclusion Criteria
* medications that affect glucose (sugar) levels
* kidney disease
* liver disease
* heart/cardiovascular disease
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth S Polonsky, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00-0589
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.